UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):August 26, 2013
Vision-Sciences, Inc.
(Exact name of registrant as specified in its charter)
Delaware | 000-20970 | 13-3430173 |
(State or other jurisdiction of incorporation) | (Commission file number) | (IRS employer identification no.) |
| | |
40 Ramland Road South Orangeburg, NY | 10962 |
(Address of principal executive offices) | (Zip code) |
Registrant's telephone number, including area code: (845) 365-0600
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: |
|
[ ] | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
[ ] | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14[a-12) |
[ ] | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
[ ] | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 5.07. Submission of Matters to a Vote of Security Holders.
On August 26, 2013, Vision-Sciences, Inc. (the “Company”) held its 2013 Annual Meeting of Stockholders (“Annual Meeting”). Each proposal subject to a vote at the Annual Meeting was described in detail in the Company's 2013 Proxy Statement. At the Annual Meeting, the Company’s stockholders (1) elected each of the nominees listed below to the Board of Directors for a term expiring in 2016; (2) ratified the appointment of EisnerAmper LLP as the Company’s independent registered public accounting firm for the fiscal year ended March 31, 2014; (3) approved an advisory resolution on executive compensation; and (4) approved holding an advisory vote on the frequency of the advisory vote on executive compensation every three years.
Set forth below are the voting results for each proposal.
1. Election of Class I Directors (Proposal 1)
| For | Withheld | Abstentions | Broker Non-Votes |
Lewis C. Pell | 20,348,866 | 160,817 | - | 16,681,359 |
John J. Rydzewski | 20,345,365 | 164,318 | - | 16,681,359 |
2. Ratification of the Audit Committee's appointment of EisnerAmper LLP as the Company's independent registered public accounting firm for the fiscal year ended March 31, 2014 (Proposal 2)
For | Against | Abstentions |
36,750,743 | 439,163 | 1,136 |
3. Advisory Vote On Executive Compensation (Proposal 3)
For | Against | Abstain | Broker Non-votes |
20,292,544 | 133,233 | 83,906 | 16,681,359 |
4. Advisory Vote On The Frequency Of The Advisory Vote On Executive Compensation (Proposal 4).
Every 1 Year | Every 2 Years | Every 3 Years | Abstain | Broker Non-votes |
2,004,845 | 62,801 | 18,231,758 | 210,279 | 16,681,359 |
There was no other business voted upon at the Annual Meeting.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, Vision-Sciences, Inc. has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| VISION-SCIENCES, INC. | |
| | |
| | | |
| By: | /s/ Howard I. Zauberman | |
| | Name: | Howard I. Zauberman | |
| | Title: | Interim Chief Executive Officer | |
Date: August 28, 2013
